Patent ID: 7097860

Claim:
A method of treating inflammation in mammals by intraperitoneally administering substantial amounts of magnesium salts into the intraperitoneal cavity for absorption by the mammal to accelerate the natural healing process in the mammal, including the steps of: forming a solution which contains magnesium salts in a range of approximately 1.2% to 12% W/V; and intraperitoneally administering an amount of the solution to a mammal in need of treatment for inflammation, so that the magnesium is absorbed into the mammal via the intraperitoneal cavity in substantial quantities (i) which would be toxic for that mammal's body weight if administered via intravenous or intramuscular injection, and (ii) which are effective to raise the level of magnesium in the mammal's body to a higher than normal level of magnesium, wherein said higher than normal level of magnesium is utilized by the mammal to produce increased levels of adenosine triphosphate which carry chemical energy throughout the mammal's body and which is used in the normal cellular level process of reducing inflammation; whereby the reduction of inflammation in the treated mammal is accelerated by absorption via the intraperitoneal said of substantial quantities of magnesium salts into the mammal which in turn raises the magnesium level in the body to a higher than normal level.